Stay updated on Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Sign up to get notified when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.

Latest updates to the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page
- Check3 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check10 days agoNo Change Detected
- Check17 days agoNo Change Detected
- Check32 days agoChange Detected- Revision tag updated from v3.4.3 to v3.5.0; no substantive updates to the study details are evident.SummaryDifference0.1%

- Check39 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no visible changes to study content or page functionality.SummaryDifference0.1%

- Check68 days agoChange DetectedAdded site revision banner 'Revision: v3.4.2'; removed the previous revision banner 'Revision: v3.4.1' and the government funding status notice. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check75 days agoChange DetectedA government funding lapse notice with operating status links was added, and the site version was updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check82 days agoChange DetectedAdded UI label Show glossary and metadata entries Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while removing Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo40 in Relapsed Hodgkins Lymphoma Clinical Trial page.